(Q37257345)

19 August 2017

Amantadine extended release for levodopa-induced dyskinesia in Parkinson's disease (EASED Study) (English)

1 reference

19 August 2017

1 reference

1 reference

1 reference

3

Robert A Hauser

1 reference

19 August 2017

1

Rajesh Pahwa

1 reference

19 August 2017

2

Caroline M Tanner

1 reference

19 August 2017

Kapil Sethi

4

1 reference

19 August 2017

Stuart Isaacson

5

1 reference

19 August 2017

Daniel Truong

6

1 reference

19 August 2017

Lynn Struck

7

1 reference

19 August 2017

April E Ruby

8

1 reference

19 August 2017

Natalie L McClure

9

1 reference

19 August 2017

Gregory T Went

10

1 reference

19 August 2017

Mary Jean Stempien

11

1 reference

19 August 2017

language of work or name

English

0 references

publication date

4 February 2015

1 reference

19 August 2017

1 reference

19 August 2017

30

1 reference

19 August 2017

788-795

1 reference

19 August 2017

6

1 reference

Which dyskinesia scale best detects treatment response?

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5024015

Calibration of unified Parkinson's disease rating scale scores to Movement Disorder Society-unified Parkinson's disease rating scale scores

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5024015

Psychosis in Parkinson's disease without dementia: common and comorbid with other non-motor symptoms

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5024015

Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5024015

Amantadine for levodopa-induced dyskinesias: a 1-year follow-up study

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5024015

Comparative toxicity of amantadine hydrochloride and rimantadine hydrochloride in healthy adults

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5024015

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5024015

Treatment patterns and associated costs with Parkinson's disease levodopa induced dyskinesia.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5024015

Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson's disease

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5024015

A 12-year population-based study of psychosis in Parkinson disease.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5024015

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results

3 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FMDS.26159

Double blind study using amantadine hydrochloride in the therapy of Parkinson's disease.

21 January 2018

1 reference

12 December 2020

Amantadine in the Treatment of Parkinson's Disease

1 reference

12 December 2020

Long-term antidyskinetic efficacy of amantadine in Parkinson's disease

1 reference

12 December 2020

Parkinson's disease home diary: further validation and implications for clinical trials

1 reference

12 December 2020

Identifiers

DOI

10.1002/MDS.26159

1 reference

19 August 2017

1 reference

19 August 2017

1 reference